Concepedia

Yananlan Chen

YC

Statistics

Publications

8

Citations

156

H-Index

8

Active since

2022

Affiliations

Nanjing Medical University(Current)

Jiangsu Province Hospital

Chinese Academy of Medical Sciences & Peking Union Medical College

Chinese Academy of Medical Sciences Dermatology Hospital

Wuxi People's Hospital

Yananlan Chen is an author at Nanjing Medical University specializing in molecular oncology, oncology, and medicine.

Publications per year

2022–2024

8

Publications

8

Hypoxia-induced SKA3 promoted cholangiocarcinoma progression and chemoresistance by enhancing fatty acid synthesis via the regulation of PAR-dependent HIF-1a deubiquitylation

Yananlan Chen, Xiao Xu, Yirui Wang et al. · Journal of Experimental & Clinical Cancer Research · 2023 · 40 citations · Full text

, , +13

USP21 deubiquitinates and stabilizes HSP90 and ENO1 to promote aerobic glycolysis and proliferation in cholangiocarcinoma

Xiao Xu, Yananlan Chen, Shenye Shao et al. · International Journal of Biological Sciences · 2024 · 28 citations · Full text

, , +14

ACSL4 serves as a novel prognostic biomarker correlated with immune infiltration in Cholangiocarcinoma

Shuochen Liu, Shilong Fan, Yirui Wang et al. · BMC Cancer · 2023 · 21 citations · Full text

, , +17

NUF2 Drives Cholangiocarcinoma Progression and Migration via Inhibiting Autophagic Degradation of TFR1

Jijun Shan, Wangjie Jiang, Jiang Chang et al. · International Journal of Biological Sciences · 2023 · 17 citations · Full text

, , +17

Exosome‐derived <scp>miR</scp>‐182‐5p promoted cholangiocarcinoma progression and vasculogenesis by regulating <scp>ADK</scp>/<scp>SEMA5a</scp>/<scp>PI3K</scp> pathway

Jifei Wang, Wangjie Jiang, Shuochen Liu et al. · Liver International · 2023 · 16 citations

, , +17

1–5 of 8